Q: Please tell me the benefits of pomegranate juice. I have heard that it prevents lung cancer is this true & if so is it substantiated? I currently use acai-max twice a day is there a benefit to adding pomegranate to this therapy? My father lost his battle with lung cancer 5 years ago. A non-smoker, he had none of the typical catalysts for the disease. Thank you for your time to answer this question, sincerely, Doris Chavez

A: Doris,

Here is a lot of easy to read data on the pomegranate – http://en.wikipedia.org/wiki/Pomegranate

As far as cancer goes: Research suggests that pomegranate juice may be effective against prostate cancer^[14][15] and osteoarthritis.^[16] In 2007, six clinical trials in the United States, Israel and Norway have been approved to examine the effects of pomegranate juice consumption on parameters of prostate cancer or prostatic hyperplasia, diabetes or lymphoma ^[17].

Both acai and pomegranate are high in unique/different polyphenols, so both together would be better than each one separately.

Sincerely,

Marcus Ettinger DC, BSc.

American pharmaceutical giant Merck & Co. for years held offshore accounts in Bermuda to hold patents for two of its drugs, and then used the royalties from these patents as tax deductions in the United States.

On Wednesday, the company agreed to pay $2.3 billion to the Internal Revenue Service, settling a three-year tax evasion dispute.

• The settlement is the second-largest ever for the IRS. The first? British pharmaceutical company GlaxoSmithKline settling for $3.4 billion.

• The Merck settlement was significantly less than the $3.8 billion the IRS was seeking, but it avoids a lengthy tax fraud lawsuit.

• The tax shelter Merck set up in the Bermudas for its subsidiary company meant the company was essentially deducting money used to pay itself.

• The drugs involved were Zocor and Mevacor, both extremely popular and profitable drugs for cholesterol.

• Merck reported $22.6 billion in sales for 2006, and said it does not expect its bottom line to be affected by the settlement.

• Merck & Co. is an American company with German origins – Merck came from Germany, but was seized by the United States and forcibly split from its parent company at the end of World War I.

• “Generally, a settlement is safer for both sides than rolling the dice,” Martin G. Laffer, a certified public accountant, told the L.A. Times newspaper. Laffer often testifies in tax fraud cases.

By: Marcus S. Ettinger DC, BSc.

1. Gold Isolate Plus contains an ample supply of the amino acid cysteine. Cysteine appears to enhance glutathione levels, which has been shown to have strong antioxidant properties. (Counous, 2000). Low glutathione contributes to oxidative stress, which plays a key role in aging and the pathogenesis of many diseases (including Alzheimer’s disease, Parkinson’s disease, liver disease, cystic fibrosis, sickle cell anemia, HIV, AIDS, cancer, heart attack, stroke, and diabetes).

2. Gold Isolate Plus can help enhance memory as it promotes the synthesis of the neurotransmitter serotonin, which is involved in cognition and thought. (Markus 2002)

3. Gold Isolate Plus contains casokinins and lactokinins, (FitzGerald 2004) which have been found to decrease both systolic and diastolic blood pressure in hypertensive humans. (Seppo 2003)

4. Gold Isolate Plus can aid in inhibiting cholesterol absorption in the gut, reducing the risk of obesity and cardiac disease. (Nagaoka 1996)

5. Gold Isolate Plus contains lactoferrin. There are research studies that have proven lactoferrins anti-cancer and immune enhancing properties. (Sakamoto 1998, Tsuda 1998, Ushida 1998, Yoo 1997)

6. Gold Isolate Plus contains lactoferrin. Studies have shown that E. Coli, Candida Albicans, H. Pylori and many other pathogenic forms of bacteria are strongly or partially (inhibited, reduced, suppressed) in the presence of lactoferrin. (Dial 1998) Note: There is a peptic ulcer H. Pylori connection and a Chronic Fatigue Syndrome candida connection. E. Coli is one of the most common causes of septic shock. Septic shock is the most frequent cause of death for intensive care patients and the 13th leading cause of death in the United States (Dr. E)

7. Gold Isolate Plus contains Branched Chain Amino Acids BCAA’s and extra L-Glutamine, which helps to maintain lean muscle mass, preserve existing muscle mass and aid in muscle protein synthesis (new muscle formation). Aging is associated with progressive loss of muscle mass, which increases the risks of injury and disability. Note: I first gave my grandmother whey protein when she was 83 years of age, she took it twice a day for the next 13 years. (Dr. E)

8. Gold Isolate Plus is your protein source with the highest Biological Value (BV), highest percentage of protein digestibility (PD), second highest Amino Acid Score (AAS) and Protein Efficiency Ratio (PER). (World Health Organization, U.S. Dairy Export Council) Note: Ounce for ounce the best protein source available! (Dr. E.)

9. Gold Isolate Plus can be added into you diet to improve body composition, power and strength. Whey protein taken before exercise has shown to maintain lean muscle while increasing the consumption of body fat for fuel. (Bouthegourd 2002)

10. Gold Isolate Plus when taken with one of CAOH’s Therapy Juices and one of CAOH’s liquid vitamins can help to Increase energy level, enhance the immune system, increase endurance, reduce fat, maintain lean muscle, reduce effects of stress, promote restful sleep, enhance memory, aid in maintaining a healthy gastrointestinal tract, lower blood pressure, and much, much more (Ettinger 2006)

IN THE
Supreme Court of the United States

PAUL MASON,

Petitioner

v.

TOMMY G. THOMPSON, Secretary of Health and Human Services; BERNARD A. SCHWETZ, D.V.M., PhD, Acting Principal Deputy Commissioner of the U. S. Food and Drug Administration,

Appellees

On Petition For Writ Of Certiorari

To The United States Court of Appeals For the Ninth Circuit

PETITION FOR WRIT OF CERTIORARI

Paul Mason, PRO SE

P. O. Box 1417

Patterson, CA 95363

Tel. (408) 897-3023
THE QUESTION PRESENTED

The FDA assisted by DOJ blundered at FDA’s inception in 1930, destroying the American mineral water industry without any scientific justification, resulting in about 10 million deaths 1930-2001 from heart disease; FDA and DOJ have refused to admit or correct their mistake, despite numerous scientific studies from the NAS and other scientific authorities. The District Court noted that the deaths “may exceed the Holocaust.”

Did the Food and Drug Administration, U. S. Department of Health and Human Services, District Court, Appeals Court, and the U.S. Department of Justice violate the Bill of Rights Fifth Amendment guarantee against “deprivation of life without due process of law” by perpetuating as many as 150,000 deaths per annum (about 10 million deaths since 1930) in an archetypical bureaucratic cover-up?

TABLE OF CONTENTS

The Question Presented i

Table of Authority iii

Opinions Below 1

Jurisdiction 1

Constitutional and Statutory Provisions Involved 1

Statement of the Case 2

Compelling Reasons 3

Conclusion 4

Index to Appendices 5

Appendices 7

TABLE OF AUTHORITY

CONSTITUTIONAL PROVISION

Bill of Rights, Amendment V of the Constitution

OPINIONS BELOW

The Unpublished opinion of the United States Court of Appeals appears at Appendix A. The Unpublished opinion of the United States District Court appears at Appendix B.

JURISDICTION

The date the United States Court of Appeals decided petitioner’s case was March 22, 2001. No petition for rehearing was filed in petitioner’s case. The jurisdiction of this Court is invoked under 28 U.S.C. § 1254(1).

CONSTITUTIONAL AND STATUTORY

PROVISIONS INVOLVED:

Bill of Rights, Amendment V of the Constitution

STATEMENT OF THE CASE

Alone among the nations of the world, the U. S. Government’s Food and Drug Administration and the Department of Justice destroyed the American mineral water industry in 1930 (Appendices C, D, E), so that American bottled waters now average about 10% as much magnesium content as do bottled waters in the rest of the world (Appendices F, G). This suppression of the American mineral water industry at the very inception of the FDA was made without any scientific studies, in response to naive notions of “purity” in that benighted era. The resulting national deficiency in dietary Mg has caused vast deaths—possibly as many as 10,650,000 deaths since 1930, projecting the figures from the 1977 report of the Safe Drinking Water Committee of the U. S. National Academy of Sciences (Appendix H), which cited over 50 studies from nine countries. Many other studies confirmed that Mg-deficiency is correlated with heart disease, or causes heart disease, and that Americans are Mg-deficient. (Appendices I, J, K, L). After causing vast numbers of deaths from heart disease on a genocidal scale, the FDA and DOJ, in an archetypical bureaucratic cover-up, have sought to deny and ignore the deaths, and have taken refuge behind the Administrative Procedures Act, arguing that FDA is better equipped than the courts to evaluate FDA’s own blunder. (Appendix M-DOJ’s argument).

Petitioner has standing as a remaining remnant of the once mighty U. S. mineral water industry that existed in 1900, which was destroyed by FDA and DOJ in 1930. Petitioner also has standing because defendants caused the deaths of more than 2% of petitioner’s friends, relatives, neighbors, co-workers, and fellow Americans by depriving them of the natural Mg found in hard water a historic source of human nutrition.

The District Court ruled that although the Mg-deficient-water deaths “may over time exceed the Holocaust”, these deaths are a “political” problem, not a judicial problem; thus summary judgment and Dismissal. The Appeals Court affirmed. The District Court further admonished petitioner to institute a program of “public education” instead of litigation; petitioner affirms that he has exhausted both himself and his finances trying to counter 70 years of propaganda by FDA against mineral water. Nor has any politician publicly spoken about the Mg-deficiency deaths, despite numerous requests by petitioner. Thus the District Court’s admonition is not practical.

COMPELLING REASONS

This case is similar to the Dredd Scott case, in that it involves a Crime Against Humanity perpetuated by the government. Whereas the Dredd Scott case led to Civil War costing about 500,000 lives, the present case has already involved as many as 10 million deaths. If the court chooses not to address the Mg-in-water issue, the deaths will continue at a rate about equal to the Viet Nam War’s 60,000 deaths every 145 days. If all legal recourses become exhausted, the only remaining timely way to save millions of American lives may be the John Brown approach. While Petitioner is not willing to make the same sacrifices that John Brown made, it is more than obvious that there are many individuals willing to lay down their lives to save millions of Americans; police, firefighters, and soldiers sacrifice their lives every day to save Americans.

The FDA, Dept. of Health, and the Dept. of Justice are all part of the Executive Branch of government that originated and perpetuated this Crime Against Humanity. It is the Constitutional province of the Judicial Branch, and this Court in particular, to act as a Check and Balance on the Executive Branch, to stop this unconstitutional “deprivation of life without due process of law.”

CONCLUSION

This Petition for a Writ of Certiorari should be GRANTED.

DATED: June 5, 2001

Respectfully submitted,

Paul Mason, Petitioner pro se

By GARDINER HARRIS
Published: July 21, 2006

WASHINGTON, July 20 Medication errors harm 1.5 million people and kill several thousand each year in the United States, costing the nation at least $3.5 billion annually, the Institute of Medicine concluded in a report released on Thursday.

Drug errors are so widespread that hospital patients should expect to suffer one every day they remain hospitalized, although error rates vary by hospital and most do not lead to injury, the report concluded.

The report, “Preventing Medication Errors,” cited the death of Betsy Lehman, a 39-year-old mother of two and a health reporter for The Boston Globe, as a classic fatal drug mix-up. Ms. Lehman died in 1993 after a doctor mistakenly gave her four times the appropriate dose of a toxic drug to treat her breast cancer.

Recommendations to correct these problems include systemic changes like electronic prescribing and tips for consumers like advising patients to carry complete listings of their prescriptions to every doctor’s visit, the report said.

“The incidence of medication errors was surprising even to us,” said J. Lyle Bootman, dean of the University of Arizona College of Pharmacy. “The solutions are complex and far-reaching and will present challenges.”

The report is the fourth in a series done by the institute, the nation’s most prestigious medical advisory organization, that has called attention to the enormous health and financial burdens brought about by medical errors.

The first report, “To Err Is Human,” was released in 1999 and caused a sensation when it estimated that medical errors of all sorts led to as many as 98,000 deaths each year;  more than was caused by highway accidents and breast cancer combined.

After the first report, health officials and hospital groups pledged reforms, but many of the most important efforts have been slow to take hold.

Drug computer-entry systems, which are supposed to ensure that hospital patients get the right drugs at the right dose, are used in just 6 percent of the nation’s hospitals, said Charles B. Inlander, president of the People’s Medical Society, a consumer advocacy group, and an author of the report released Thursday.

Electronic medical records can help ensure that patients do not receive toxic drug combinations. The 1999 report urged widespread adoption of these systems. Thursday’s report called for all prescriptions to be written electronically by 2010.

Just 3 percent of hospitals have electronic patient records, said Henri Manasse, chief executive of the American Society of Health-System Pharmacists. Few doctors prescribe drugs electronically.

Even simple medication safety recommendations – block printing on hand-written prescription forms – are widely ignored.

Arthur Levin, director of the Center for Medical Consumers and an author of the 1999 report, said that just about everyone in the health system was to blame. “This country has not taken seriously the alarms we sounded in 1999,” Mr. Levin said. “Why?”

Health organizations defended their efforts.

Alicia Mitchell, a spokeswoman for the American Hospital Association, said that since 1999 hospitals had “actively engaged in looking at using information technology to improve patient safety.”

A recent poll by the association of its members found that 92 percent intended to adopt electronic patient records, Ms. Mitchell said. But such systems are complicated and need to be built gradually, she said.

Thursday’s report urged the Food and Drug Administration to improve and standardize the drug information leaflets given consumers. It noted that confusing information on drug labels was an important cause of medication errors.

On Tuesday, the drug agency finished a years-long process by issuing voluntary guidelines to reform consumer drug information leaflets, said Dr. Scott Gottlieb, the agency’s deputy commissioner. Many of these leaflets are not regulated by the F.D.A.

And on June 30, the agency completed a lengthy effort to clarify and standardize information on drug labels. The new labels could prevent nearly 300,000 medication errors each year and will make electronic prescribing efforts far easier to carry out, Dr. Gottlieb said.

Thursday’s report said that the common practice whereby drug companies provided free drug samples to doctors should be discouraged because such samples were poorly controlled. It urged drug makers to package more pills in individual packages. And it criticized drug makers as failing to disclose the results of all clinical trials involving their drugs.

Alan Goldhammer, a spokesman for the Pharmaceutical Research and Manufacturers of America, a drug industry trade group, said he differed with some of the report’s conclusions but concurred with the broad goals of increasing the use of information technology to reduce medication errors.

“Everybody is working on that right now,” he said.

Thursday’s report said that in any given week, four out of five adults in the United States took at least one medication. A third take at least five different medications. As the use of medications has soared, so, too have medication errors, Dr. Manasse said.

Effective strategies to prevent such errors have, however, been known for years, Mr. Inlander said.

“This is not rocket science,” Mr. Inlander said. “It’s simple. The key is having the will to make these changes in an organized and uniform way. And it’s not that expensive.”

Announcement opens door to new food labels

WASHINGTON – The monounsaturated fat in olive oil may reduce the chances of suffering coronary heart disease, the Food and Drug Administration said Monday, opening the door to revised food labels.

As long as people don’t increase the number of calories they consume daily, the FDA found “limited but not conclusive evidence” suggesting reduced risk of coronary heart disease when people replace foods high in saturated fat with the monounsaturated fat in olive oil.

According to the American Heart Association, coronary heart disease accounted for 502,189 deaths ‘or one in five deaths’ in 2001, the most current statistic available. Another 13.2 million Americans that year survived the heart attacks, chest pains and other ailments caused by coronary heart disease.

Along with lowering cholesterol, cutting out cigarettes and exercising, the group says Americans can boost heart health by eating foods low in saturated fat, cholesterol and sodium. An American Heart Association spokeswoman declined comment on the FDA’s action until it reviews the health claim.

“Since CHD is the No. 1 killer of both men and women in the United States, it is a public health priority to make sure that consumers have accurate and useful information on reducing their risk,” Lester M. Crawford, acting FDA commissioner said in a prepared statement.

It’s the third time the FDA granted a qualified health claim for conventional food.

Olive oil and certain food containing olive oil can now indicate that “limited and not conclusive scientific evidence suggests that eating about two tablespoons (23 grams) of olive oil daily may reduce the risk of coronary heart disease due to the monounsaturated fat in olive oil,” the agency said.

By GARDINER HARRIS
Published: June 30, 2006

WASHINGTON, June 29 ” Federal drug regulators issued a strong warning Thursday that Ketek, a controversial antibiotic, could in rare circumstances cause serious liver injury, liver failure and even death.

“We clearly now understand that there is risk of serious liver injury with Ketek,” said Dr. John Jenkins, director of the Food and Drug Administration’s Office of New Drugs.

But Dr. Jenkins said the agency did not yet know whether the risks posed by Ketek were greater than those of other antibiotics, and he said the drug’s benefits outweighed its risks.

Ketek is manufactured by Sanofi-Aventis, the French drug giant, and it has been approved to treat bronchitis, sinusitis and mild-to-moderate pneumonia.

In a written statement, Dr. Sol Rajfer, president of science and medical affairs in the United States for Sanofi-Aventis, said, “We continue to believe that the benefits of Ketek outweigh the risks when the drug is used as directed for its approved indications.”

Thursday’s announcement was the culmination of months of internal debate in the drug agency about how to address Ketek’s risks, according to internal agency memorandums obtained by The New York Times. In addition to liver problems, Ketek can cause blurred vision and loss of consciousness. In patients with myasthenia gravis, a rare neurological disorder, it can cause death.

Fourteen adult patients in the United States have suffered liver failure after taking Ketek. At least four of them have died; 23 others suffered serious liver injury.

One F.D.A. safety reviewer in May called for a halt to Sanofi-Aventis’s tests of Ketek in children with ear infections, arguing that cutting the duration of ear pain by one day was hardly worth risking death.

Shortly after The Times reported these concerns, Sanofi-Aventis announced a “pause” in its pediatric clinical trials.

“We’re continuing to have discussions about those studies and whether they can resume,” Dr. Jenkins said.

Other antibiotics cause liver failure, but Ketek seems to do so almost four times as often, safety officials concluded in a review.

But in Thursday’s briefing, agency officials said that comparing liver-failure rates across antibiotics was fraught with problems.

“So while the number for Ketek may be higher than the others, direct comparisons are really difficult to make,” said Dr. Gerald DalPan of the division of epidemiology and surveillance at the agency.

New warnings on Ketek’s label suggest that patients who appear jaundiced or who suffer any other signs of liver injury should stop taking the drug.

Because Ketek has been reported to cause severe liver injury in patients after only a few doses, Dr. Jenkins was asked how patients could follow this advice.

“We’re providing the best possible advice to doctors to be aware of this risk and to make sure their patients are aware,” he replied.

The drug agency’s actions in regard to Ketek are being investigated by Senator Charles E. Grassley, the Iowa Republican who is chairman of the Finance Committee, and by Representatives Edward J. Markey of Massachusetts and Henry A. Waxman of California, both Democrats.

Mr. Grassley released a statement Thursday, saying, “Ketek is another example where the F.D.A. accommodated a drug maker and turned a blind eye to serious safety concerns.”

Dr. Jenkins explained that new antibiotics were desperately needed since growing resistance to antibiotics gradually rendered older drugs ineffective.